CClinicalTrials.gg
CompletedNCT05944159Updated Jul 27, 2023

Temporomandibular Joint and Soft Tissue Mobilisation Techniques on Bening Paroxymal Vertigo

An interventional study of Study Group and Control Group in Soft Tissue Mobilisation, Vestibular Exercises and Physiotherapy, sponsored by Alanya Alaaddin Keykubat University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-07-27.

Sponsored by Alanya Alaaddin Keykubat University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Jul 2022, registered Apr 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
41
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study was to investigated effectiveness of temporamandibular joint and soft tissue mobilization on patients with Benign Paroxysmal Positional Vertigo (BPPV).

Read the detailed description

Aim: In this study was aimed to investigated effectiveness of temporamandibular joint and soft tissue mobilization on patients with Benign Paroxysmal Positional Vertigo (BPPV). Material and Methods; Dix Hallpike maneuver was administered to all patients to confirm the diagnosis at the initial evaluation. If the Dix Hallpike test was positive, Epley maneuver was applied The patients were randomly divided into 2 groups as study group (n=) and control groups (n= ). Temporomandibular joint ve soft tissue techniques were applied 30 minutes once a week for 4 weeks by physiotherapist. Routin medication therapy was applied to control group. Both groups were asked to do the home exercise program twice a day consisting of vestibular exercise videos sent over whatss app. It was questioned with a phone call once a week whether the exercises were done or not. Patients were evaluated by Dizziness Disability Inventory (DHI) , Dizziness Assessment- Visual Analogue Scale (VAS), Vertigo Symptom Scale-Short Form (VSS) , Beck Anxiety Inventory (BAI) , Vertigo Dizziness Imbalance Questionnaire (VDI) , Tinnitus Disability Scale (TDS), Romberg Posture Test , Tandem Posture Test, Semitandem Tandem Balance Test, Fonseca's Anamnestic Index (FAI) and amount of mouth opening was measured with goniometer before and after treatment.

02

Conditions studied

  • Soft Tissue Mobilisation
  • Vestibular Exercises
  • Physiotherapy
  • Vertigo, Paroxysmal
  • Temporomandibular Joint Disorders

Keywords

  • Bening Paroxymal Positional Vertigo
  • Temporomandibular Joint Mobilization
  • Soft Tissue Mobilisation
  • Vestibular Exrecises
  • Physiotherapy
  • Otorhynology
03

In context

Temporomandibular Joint Disorders

609 studies on the registry are indexed under Temporomandibular Joint Disorders; 160 are open to participants now.

This study's enrollment of 41 is below the median of 46 across 434 interventional studies indexed under Temporomandibular Joint Disorders.

Browse Temporomandibular Joint Disorders studies →

Lead sponsor

Alanya Alaaddin Keykubat University is the lead sponsor of 44 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Being diagnosed with positional vertigo,
  • Being between the ages of 18-65
  • Dix Halpike maneuver test (+),
  • Those who volunteered to participate in the study
  • Able to read and write.

Exclusion criteria

Exclusion Criteria:

  • Findings of acute or chronic infection at the end of ENT examination,
  • Considered to have a neurological pathology that causes dizziness,
  • Head trauma, history of surgical operation,
  • Having lower extremity pain that prevents standing and weight bearing,
  • Having a history or symptoms of vestibular system diseases other than BPPV,
  • Presence of sudden sensory hearing loss and chronic otitis media,
  • Pregnancy,
  • The presence of serious cognitive impairment detected by the physician at a level that prevents the tests from being performed,
  • Not having the mental level to understand and answer the survey questions,
  • Cervical pathologies that may cause dizziness.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
41 participants (actual)

Study arms

  • Experimental
    Study Group

    Study Group (n= 20) was recieved Temporomandibular joint ve soft tissue techniques. The techniques were applied 30 minutes once a week for 4 weeks by physiotherapist to the study group.

    Behavioral: Study Group

  • Other
    Control Group

    Control group (n=20) was received routin medication therapy was applied. Both groups were asked to do the home exercise program twice a day consisting of vestibular exercise videos sent over whatss app. It was questioned with a phone call once a week whether the exercises were done or not.

    Other: Control Group

Interventions

  • BehavioralStudy Group

    Study Group (n= 20) was recieved Temporomandibular joint ve soft tissue techniques. The techniques were applied 30 minutes once a week for 4 weeks by physiotherapist to the study group.

  • OtherControl Group

    Routin medication therapy was applied to the control group. Both groups were asked to do the home exercise program twice a day consisting of vestibular exercise videos sent over whatss app. It was questioned with a phone call once a week whether the exercises were done or not.

06

What researchers measure

Primary outcomes

  1. Dizzness Severity

    dizziness severity was determined by Visual Analog Scale (VAS). The patient is asked to evaluate between 0 and 10 points. A score of "0" means no dizziness, a score of "1-4" means mild dizziness, a score of "4-8" means moderate dizziness, and a score of "10" means unbearable dizziness

    Time frame: Baseline - end of the treatment after 4 weeks session

  2. Vertigo Symptom Scale- Shor Form

    It is a 15-item scale that evaluates dizziness, feeling of imbalance, accompanying autonomic disorders and anxiety symptoms in the last 1 month.Each question has values between 0-4 points. The scores of all items will be added together and the total score will be between 0-60 points. High scores indicate serious problems. A total score of 12 points or more indicates a symptom of vertigo. It has 8 items related to vertigo and has a score between 0-32 points, it has 7 items that includes autonomic complaints and has a score of 0-28.

    Time frame: Baseline - end of the treatment after 4 weeks session

  3. Beck Anxiety Inventory

    It were used for to evaluate of anxiety level because of the vertigo. It consists of 21 questions in total. 0 points: none, 1. point: mild 2. points: intermediate, 3. points: seriously scored. It was classified as mild anxiety symptoms between 8-15 points, moderate anxiety symptoms between 16-25 points, and severe anxiety symptoms between 26-63 points.

    Time frame: Baseline - end of the treatment after 4 weeks session

  4. Vertigo Dizziness Imbalance Questionnaire (VDI)

    The Vertigo-Dizziness-Imbalance Questionnaire is a scale that evaluates the quality of the daily living activities of the problems that patients experience with vertigo and dizzines.Each question has a point value of "4" points if yes, "0" points if no, and sometimes "2" points. In the scoring, 28 points are the limit points for determining physical disability, 36 points for functional and sensory disability.

    Time frame: Baseline - end of the treatment after 4 weeks session

  5. Tinnitus Disability Scale

    The Tinnitus Disability Scale (TDS) was used for the presence and level of balance tinnitus due to vertigo.TDS has 25 questions. The scoring of the answers is "4", "0" and "2" respectively. The lowest score that can be obtained from the scale is 0 and the highest score is 100.

    Time frame: Baseline - end of the treatment after 4 weeks session

  6. Balance Asssesment

    Balance problems due to vertigo were determined by romberg test, tandem and semitandem tests. Romberg Test:In peripheral vestibular pathologies, the direction of the fall is in that direction. For the Tandem and Semitandem tests,It is asked to try to hold the position for 30 seconds with your open eyes closed. The time it can stand is recorded in seconds

    Time frame: Baseline - end of the treatment after 4 weeks session

  7. The presence of Temporomandibular Joint Disorders

    The presence and level of temporomandibular dysfunction was determined by Fonseca's Anamnestic Index (FAI). FAI is a questionnaire consisting of 10 questions and 3 choices. The answers are "yes" (10 points), "sometimes" (5 points), and "no" (0 points). Scoring TMD No signs or symptoms (0-15 points), mild TMD (20-45 points), moderate TMD (50-65 points), and severe TMD (70-100 points)

    Time frame: Baseline - end of the treatment after 4 weeks session

  8. Mouth opening

    amount of mouth opening was measured with goniometer before and after treatment.

    Time frame: Baseline - end of the treatment after 4 weeks session

07

Study locations

1 site
  • Alanyaaku
    Antalya, Alanya, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05944159
Lead sponsor
Alanya Alaaddin Keykubat University
Responsible party
Ayça Araci (Dr, Head of Physiotherapy and Rehabilitation Department, Alanya Alaaddin Keykubat University) — Principal investigator
First posted
Jul 13, 2023
Start date
Jul 7, 2022
Primary completion
Dec 7, 2022
Completion
Feb 20, 2023
Last update
Jul 27, 2023

Study contacts

Ayça ARACI, PhD
study director · Physiotherapy and Rehabilitation
Dilara GÜLER, Master
principal investigator · Physiotherapy and rehabilittaion

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion